Journal
Blood Advances
Publication Date
2019
Volume
3
Issue
23
First Page
3982
Last Page
4001
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2019000882
Rights and Permissions
Ann T. Farrell, Julie Panepinto, C. Patrick Carroll, Deepika S. Darbari, Ankit A. Desai, Allison A. King, Robert J. Adams, Tabitha D. Barber, Amanda M. Brandow, Michael R. DeBaun, Manus J. Donahue, Kalpna Gupta, Jane S. Hankins, Michelle Kameka, Fenella J. Kirkham, Harvey Luksenburg, Shirley Miller, Patricia Ann Oneal, David C. Rees, Rosanna Setse, Vivien A. Sheehan, John Strouse, Cheryl L. Stucky, Ellen M. Werner, John C. Wood, William T. Zempsky; End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain. Blood Adv 2019; 3 (23): 3982–4001. doi: https://doi.org/10.1182/bloodadvances.2019000882
Recommended Citation
Farrell, Ann T.; King, Allison A.; and al., et, "End points for sickle cell disease clinical trials: Patient-reported outcomes, pain, and the brain." Blood Advances. 3, 23. 3982 - 4001. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8572
